Posted by Michael Wonder on 06 Mar 2017
Drug pricing report shows scope for more savings
6 March 2017 - The savings to the taxpayer in reducing the cost to Government of prescribed pharmaceuticals has been one of the success stories in health economics in Australia in recent years, yet experts say even more savings may be possible through changes to drug pricing policy, the Consumers Health Forum said today.
Responding to a new report from the Grattan Institute, Cutting a better drug deal, the CEO of the Consumers Health Forum, Leanne Wells, said the report’s findings are a timely contribution to future thinking on medicines policy and highlight the value of ongoing scrutiny and review of pricing policy.
